Thioether derivatives

US7005526B2 · kind B2 · utility

Assignee

• Hoffmann-La Roche Inc. · US

Inventors

• Birgit Bossenmaier · Hanerau-Hademarschen, DE
• Walter-Gunar Friebe · Mannheim, DE
• Thomas Friess · Planegg, DE
• Lothar Kling · Mannheim, DE
• Ulrike Reiff · Penzberg, DE
• Edgar Voss · Bichl, DE

Key dates

• Filing date: May 18, 2005
• Grant date: Feb 28, 2006
• Expiry date: May 18, 2025

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Objects of the present invention are the compounds of formula (I) formula (I), their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above compounds in the control or prevention of illnesses such as cancer.